{"id":"W2905845365","doi":"10.1016/j.eururo.2018.12.015","title":"Health-related Quality of Life for Abiraterone Plus Prednisone Versus Enzalutamide in Patients with Metastatic Castration-resistant Prostate Cancer: Results from a Phase II Randomized Trial","year":2018,"lang":"en","type":"article","venue":"European Urology","topic":"Prostate Cancer Treatment and Research","field":"Medicine","cited_by":73,"is_retracted":false,"has_abstract":false,"ca_institutions":"University of British Columbia; Abbotsford Veterinary Clinic; Fraser Health; BC Cancer Agency","funders":"","keywords":"Medicine; Enzalutamide; Prostate cancer; Prednisone; Abiraterone; Randomized controlled trial; Quality of life (healthcare); Oncology; Internal medicine; Abiraterone acetate; Androgen deprivation therapy; Urology; Cancer; Androgen receptor; Nursing","routes":{"ca_aff":true,"ca_fund":false,"ca_venue":false,"about_ca":false,"invisible_to_affiliation_only":false},"retraction":null,"screen":null,"direct_labels":[],"prediction":{"model_version":"metacan-v3-hybrid-931329e0061c","candidate_categories":[],"consensus_categories":[],"category_scores_codex":[0.001530222,0.001632867,0.002473802,0.0003830377,0.0004195003,0.001145763,0.000800135,0.001102012,0.003255218],"category_scores_gemma":[0.001855873,0.0005473415,0.002359384,0.0005576868,0.001260865,0.0008670511,0.0004482397,0.002800422,0.0004099833],"about_ca_system_candidate":false,"about_ca_system_consensus":false,"about_ca_system_score_codex":0.0008831301,"about_ca_system_score_gemma":0.001129932,"about_ca_topic_candidate":false,"about_ca_topic_consensus":false,"about_ca_topic_score_codex":0.002277689,"about_ca_topic_score_gemma":0.004248142,"domain_scores_codex":[0.9992476,0.0004148873,0.00005138218,0.0001223833,0.00006467346,0.00009919052],"domain_scores_gemma":[0.9989274,0.0003759231,0.0002772706,0.00007561239,0.00004517666,0.0002987019],"domain_codex":null,"domain_gemma":null,"domain_candidate":null,"domain_consensus":null,"study_design_codex":"randomized_trial","study_design_gemma":"randomized_trial","study_design_scores_codex":[0.9819941,0.002652576,0.001084479,0.0003690697,0.001556775,0.00002229356,0.00004389529,0.0004816288,0.0008782019,0.00004264454,0.0002542296,0.01061999],"study_design_scores_gemma":[0.9517089,0.04222987,0.003534343,0.0000348307,0.00142938,0.00002865134,0.0000326232,0.0003931694,0.0001979499,0.0001263619,0.0002693877,0.00001443232],"study_design_candidate":"randomized_trial","study_design_consensus":"randomized_trial","genre_codex":"empirical","genre_gemma":"empirical","genre_scores_codex":[0.9917371,0.005035289,0.0003351141,0.0004759942,0.0002264359,0.0007467174,0.0005094687,0.00004845454,0.0008854551],"genre_scores_gemma":[0.9946543,0.002128957,0.0005413041,0.0003956602,0.0001945183,0.0006627414,0.0005620205,0.00001084115,0.0008496145],"genre_candidate":"empirical","genre_consensus":"empirical","teacher_disagreement_score":0.003255218,"threshold_uncertainty_score":0.01088977,"prediction_status":"machine_predicted_unvalidated"},"machine_scores":{"provisional":true,"baseline":true,"maturity_gate_passed":false,"score_opus":0.07043159014875042,"score_gpt":0.3704435745394552,"score_spread":0.3000119843907048,"validation_status":"score_only:v0-immature-baseline","note":"Baseline scores from an immature model (maturity gate not passed). Scores rank; they never assert a category."}}